EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Angiogenesis and targeted therapy in the tumour microenvironment: From basic to clinical practice

Shuaixi Yang, Yingshuai Fang, Yangcheng Ma, Fuqi Wang, Yuhang Wang, Jiachi Jia, Yabing Yang, Weipeng Sun, Quanbo Zhou, Zhen Li

Clinical and Translational Medicine · 2025-04 · 15 (4)

DOI: 10.1002/ctm2.70313 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical and Translational Medicine, online erschienen am 23.04.2025. Verfasst von Shuaixi Yang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Colorectal Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. Hauptthemen laut MEDLINE: Tumor Microenvironment, Neovascularization, Pathologic, Neoplasms, Angiogenesis Inhibitors. Die Arbeit wurde bisher 57-mal zitiert (Crossref) und nennt 257 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: China Postdoctoral Science Foundation, National Fund Postdoctoral Researcher Program, Henan Medical Science and Technology Research Plan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Angiogenesis, as a core marker of cancer survival and growth, is integral to the processes of tumour growth, invasion and metastasis. In recent years, targeted angiogenesis treatment strategies have gradually become an important direction in cancer treatment. Single‐cell sequencing technology can provide new insights into targeted angiogenesis by providing a deeper understanding of the heterogeneity of tumour endothelial cells and exploring the interactions between endothelial cells and surrounding cells in the tumour microenvironment. Here, we systematically review the research progress in endothelial cell pathophysiology and its endothelial‒mesenchymal transition and illustrate the heterogeneity of endothelial cells from a single‐cell perspective. Finally, we examine the contributions of different cell types within the tumour microenvironment in relation to tumour angiogenesis, as well as the latest progress and strategies in targeted angiogenesis therapy, hoping to provide useful insights into the clinical application of antiangiogenic treatment. Furthermore, a summary of the present progress in the development of potential angiogenesis inhibitors and the ongoing clinical trials for combination therapies is provided. Key points Angiogenesis plays a key role in tumour progression, invasion and metastasis, so strategies targeting angiogenesis are gradually becoming an important direction in cancer therapy. Interactions between endothelial cells and stromal cells and immune cells in the tumour microenvironment are significant in angiogenesis. The application of antiangiogenic immunotherapy and nanotechnology in antiangiogenic therapy provides a vital strategy for prolonging the survival of cancer patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor MicroenvironmentNeovascularization, PathologicNeoplasmsAngiogenesis InhibitorsHumansAngiogenesis

Stichwörter der Autor:innen

EndMTangiogenesisantiangiogenic therapycancerendothelial cells

Substanzen

Angiogenesis Inhibitors

Autor:innen und Institutionen

  • Department of Colorectal Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • The First Clinical School of Medicine, Zhengzhou University, Zhengzhou, China.
  • Department of Orthopedics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

Förderung

  • China Postdoctoral Science Foundation
  • National Fund Postdoctoral Researcher Program
  • Henan Medical Science and Technology Research Plan
  • Zhengzhou University Postdoctoral Fund
  • Natural Science Foundation Youth Fund of Henan Province

Zitieren

APA

Yang, S., Fang, Y., Ma, Y., Wang, F., Wang, Y., Jia, J., Yang, Y., Sun, W., Zhou, Q., & Li, Z. (2025). Angiogenesis and targeted therapy in the tumour microenvironment: From basic to clinical practice. Clinical and Translational Medicine, 15(4). https://doi.org/10.1002/ctm2.70313

Vancouver

Yang S, Fang Y, Ma Y, Wang F, Wang Y, Jia J, et al. Angiogenesis and targeted therapy in the tumour microenvironment: From basic to clinical practice. Clinical and Translational Medicine. 2025;15(4). doi:10.1002/ctm2.70313

BibTeX
@article{Yang2025,
  author = {Yang, Shuaixi and Fang, Yingshuai and Ma, Yangcheng and Wang, Fuqi and Wang, Yuhang and Jia, Jiachi and Yang, Yabing and Sun, Weipeng and Zhou, Quanbo and Li, Zhen},
  title = {Angiogenesis and targeted therapy in the tumour microenvironment: From basic to clinical practice},
  journal = {Clinical and Translational Medicine},
  year = {2025},
  volume = {15},
  number = {4},
  doi = {10.1002/ctm2.70313}
}
Kostenlos starten →